Professional Documents
Culture Documents
2carotid Artery
2carotid Artery
2carotid Artery
2Carotid Artery
a.
b.
c.
d.
e.
f.
g.
i. The superior and inferior laryngeal branches of the vagus supply the
muscles of the larynx, and varying degrees of dysphonia result when they
are injured. The superior laryngeal nerve accompanies the artery of
the same name from its origin high in the neck and is at direct risk
from mobilization of the artery.
ii. Injury to the Superior Laryngeal Nerve will result in voice fatigue
i.
j. The recurrent laryngeal nerve, arising low in the neck, is at indirect risk from
injury to the main vagal trunk in the midneck. In rare cases, a nonrecurrent
laryngeal nerve may branch directly from the vagus at the level of the carotid
bifurcation and course medially behind the carotid bulb to reach the larynx. This
anomaly is usually seen on the right side, associated with an aberrant right
subclavian artery
i. Injury to the recurrent laryngeal nerve results in hoarseness, impaired
phonation, and an ineffective cough.
k.
i. The glossopharyngeal nerve gives sensory and motor fibers to the tongue
and pharynx which may result in aspiration in the rare instances when it is
injured due to inability to elevate larynx/pharynx
1.
2.
3.
a. The stylopharyngeus is above the digastric and can be
divided to get higher on the carotid
4. Division of the stylopharyngeus and styloglossus muscles and the
stylomandibular ligament, and removal of the styloid process, can
be beneficial.
5. The glossopharyngeal nerve should remain medial. Periadventitial
dissection of the distal cervical portion of the internal carotid artery
can help prevent injury to this structure.
6.
3.
m. Structures in Carotid Sheath:
i. Vagus Nerve: Injury can result in unilateral adductor vocal paralysis
(hoarseness), and cricopharyngeal dysfunction (dysphagia)
ii. Cervical Sympathetic
1. Embedded in the most posterior fibers of carotid sheath
iii. Ansa Cervicalis
1. Found in anterior fibers of the sheath
2. Innervation to the strap muscles (sternohyoid, sternothyroid,
thyrohyoid, omohyoid)
n. NASCET:
i. Randomized patients with symptomatic carotid stenosis > 70% into a
medical treatment (aspirin, blood pressure control) arm and a surgical
(carotid endarterectomy) arm. The risk for ipsilateral stroke at 2 years with
medical management was 26% and the risk for any stroke or death was
32%. For carotid endarterectomy, the risk for ipsilateral stroke was 9% at
2 years.
1. The benefit became apparent at 3 months and persisted for 8 years
ii. Risk of stroke in 2 years (NASCET) = 26%, reduced to 9% after CEA
iii. In 1991, NASCET demonstrated that for patients with Symptomatic carotid
stenosis 70–99%, the two year risk of ipsilateral stroke was 26% with medical
therapy vs. 9% with carotid endarterectomy.
1. In 1998, NASCET demonstrated that for patients with Symptomatic
carotid stenosis 50–69%, the five year risk of ipsilateral stroke was 22.2%
with medical therapy vs. 15.7% with carotid endarterectomy (p<.05).
2. NASCET showed strong benefit of carotid endarterectomy over best
medical therapy for symptomatic patients with 50–99% stenosis.
a. However, best medical therapy at the time did not include statins
and generally included aspirin as the only antiplatelet.
3. Echogenic plaque is calcium rich and is thought to be more stable.
4. Echolucent plaque is more consistent with lipid rich or hemorrhagic
plaque that is more likely to be unstable
iv. NASCET: In those patients with less than 50% stenosis, there was a risk
of stroke in the medical group of 18.7% and in the surgical group of
14.9% (not significant). The results of this trial support performing carotid
endarterectomy in symptomatic patients with ipsilateral carotid stenosis
greater than 50%.
o. ACAS:
i. Risk of stroke in 5 years (ACAS) = 11%, 5% after surgery. 3.9% if you
exclude the risks of carotid angiograms during the ACAS trial.
ii. 1600 Patients with a > 60% asymptomatic carotid stenosis into a surgical
(carotid endarterectomy) arm and a medical management arm (mainly
aspirin therapy). After a mean of 2.7 years of follow up, the 5-year
Kaplan-Meier projected risk for any stroke or death with medical
management alone was 11% compared to a 5.1% risk in those who
underwent carotid endarterectomy.
1. Also demonstrated that Carotid Angiogram has
Morbidity/Mortality of 1.2%, thus showed that duplex is favored
for initial diagnostics
iii. Asymptomatic Carotid Atherosclerosis Study (ACAS) and the
Asymptomatic Carotid Surgery Trial (ACST): The consensus
interpretation for the benefit of prophylactic carotid endarterectomy
compared to best medical therapy is that the relative stroke risk reduction
at 5 years was 50%, which is based on an absolute risk from 12% with
medical therapy to 6% with carotid endarterectomy. Therefore, absolute
annualized stroke risk reduction is approximately 1% to 2% for surgical
patients compared to patients managed with best medical therapy ({12%-
6%}/5 years).
iv. With respect to stroke/death, by Kaplan-Meier analysis, there was not a
statistically significant difference favoring CEA until 5 years. Similarly,
rates of stroke were not statistically significantly different until 5 years.
Closer inspection of the curves show that the KM curves do not cross until
approximately 3 years. Hence, in patients with abbreviated lifespans of 3
years or less, carotid endarterectomy cannot lower the risk of stroke
compared to best medical therapy.
p. The Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
initially evaluated 4-year outcomes and found that stroke was statistically
significantly higher within the CAS arm compared to the CEA arm (4.1% vs 2.3%
respectively, p = 0.01).
i. In the 4-year CREST trial, patients undergoing CEA had higher rates of
MI (defined as troponin elevation plus either symptoms or EKG changes).
1. Patients undergoing CAS had higher rates of minor and major
stroke.
a. However, the primary composite endpoint of MI, stroke,
and Death was not significantly different between groups.
b. Of note, even though most strokes were minor, there was a
greater decrease in quality of life for patients with stroke
compared to MI in both CEA/CAS groups
ii. In 2016, however, the CREST investigators published the 10-year follow-
up results. Their primary long-term endpoint was post-procedural
ipsilateral stroke. There was no statistically significant difference found
between stroke/MI rates between the CAS and CEA arms at 10 years
(6.9% vs 5.6%, p = 0.96).
1. However, the composite endpoint of stroke/death showed that
there was an increased risk of stroke/death in the CAS arm (HR
1.37; 95% CI 1.01-1.86)
q. Multiple randomized controlled trials have supported the safety and efficacy of
intravenous alteplase (0.9 mg/kg; maximum dose of 90 mg) for confirmed
ischemic strokes of less than 3 hours duration.
i. IV alteplase treatment in the 3- to 4.5-h time window is recommended for
those patients ≤80 y of age, without a history of both diabetes mellitus and
prior stroke
ii. Concurrent intravenous abciximab administration is a contraindication to
alteplase administration.
iii. Other contraindications include a blood pressure of 185/110 mm Hg or
higher; intracranial hemorrhage on CTA; a history of stroke, severe head
trauma, or intracerebral or intraspinal surgery within 3 months;
gastrointestinal bleeding within 21 days; and concurrent usage of low-
molecular weight heparin/thrombin or factor Xa inhibitors.
r. There are no studies to suggest endovascular intervention of asymptomatic carotid
in-stent restenosis improves patency or decreases long-term stroke rates.
s. The stroke prevention by aggressive reduction in cholesterol levels (SPARCL)
randomly assigned nearly 5,000 patients who had stroke or TIA within 1 to 6
months of enrollment to high dose (80 mg) atorvastatin per day or placebo.
i. With a 5-year follow up, the overall mortality rates were similar between
the groups; however, there was a reduction in the overall incidence of
strokes and cardiovascular events with a small increase in hemorrhagic
stroke.
1. Mortality was similar, however there were less overall events in
the treatment group. A small increase in hemorrhagic stroke was
noted in the treatment group.
t. Major trials have defined “recent” as within the past 6 months. In general, remote
events are not considered when determining whether a current lesion is
symptomatic carotid lesion.
u. Staged carotid endarterectomy (CEA) followed by CABG were associated with
the lowest stroke/death rates, with the highest stroke rates noted in those
undergoing CABG then CEA.
i. Rates of complications are comparable if carotid artery stenting is
substituted for CEA in staged or synchronous CABG. The largest
systematic review shows that mortality is highest among patients
undergoing synchronous CEA and CABG.
v. In HD patients, carotid revascularization (either CAS or CEA) is associated with
an increased perioperative stroke risk.
i. Overall, the data most consistently show an increased risk of stroke in
nonrevascularized patients with ESRD and high-grade asymptomatic
carotid artery stenoses; therefore decision to treat must be made on a case-
by-case basis
w. Both carotid endarterectomy (CEA) and carotid artery stenting (CAS) have been
studied in patients who have prior cervical radiation therapy.
i. Regardless of symptom status, periprocedural stroke and death rates are
nearly equivalent for CEA and CAS in this cohort.
ii. Increased nerve damage risk in redo-CEA
x. The standard therapy for arterial injury from a 7 Fr (or greater) catheter on the
right side of the neck is open repair by either a cervical approach or a combination
of supraclavicular approach with partial median sternotomy if there is an injury to
the innominate artery or aorta.
i. If there is involvement of the aorta, the left side of the neck may require a
posterolateral thoracotomy or even possibly a trapdoor procedure,
depending on the location of the catheterization
y. Acute Stroke Post-CEA:
i. If the patient exhibits signs of an ipsilateral stroke after awakening from
anesthesia, the artery should be evaluated for thrombosis with ultrasound.
1. If thrombus is present at the endarterectomy site, the
endarterectomy site should be explored to ensure no technical
defect.
2. If a distal embolus is suspected, percutaneous methods of
retrieving the embolus may be undertaken.
3. Systemic tPA is not recommended due to risk of bleeding.
ii. Thrombosis after post-op CEA: If no technical defect is identified on re-
exploration, the presumed etiology of the thrombosed CEA site is platelet
and fibrin aggregation, with adherence to the freshly endarterectomized
surface. If this is not replaced, there is a high chance of re-thrombosis.
Thus, it must be replaced with saphenous vein interposition
iii. Treatment:
1. Immediate:
a. re-exploration (for immediate, 1 hr delayed)
b. cerebral angiography with intra-arterial
thrombolysis (intra-cranial emboli, patent
endarterectomy site)
c. Open the wound in the OR under local
anesthesia. Why local: no hypotension on
induction.
d. Then perform intraoperative duplex. If the
duplex shows a technical defect or clot,
heparinize and open the carotid.
i. If it doesn’t, then get an angiogram
ii. If angiogram is negative, get a head CT
to look for bleed.
e. Risk of hemorrhagic conversion is high.
2. Delayed:
a. Deficit 1-2 days after CEA is usually secondary to cerebral
hemorrhage and/or edema secondary to hyperperfusion.
b. The syndrome is HTN/Headache/seizures
c. Tx = BP control and anti-seizure medications, in addition
to minimizing anticoagulation.
z. Special considerations apply to blood pressure (BP) control in patients with acute
ischemic stroke who are candidates for intravenous thrombolytic therapy.
i. Before thrombolytic therapy is started, treatment is recommended to keep
systolic BP at or below 185 mmHg and diastolic blood pressure at or
below 110 mmHg.
ii. BP should be maintained at or below 180/105 mmHg for at least 24 hours
after thrombolysis.
iii. For patients with acute ischemic stroke who are not treated with
thrombolytic therapy, a BP should not be treated acutely unless systolic
BP exceeds 220 mmHg or diastolic BP exceeds 120 mmHg, or the patient
has active ischemic coronary disease, heart failure, aortic dissection, or
hypertensive encephalopathy.
1. It is appropriate to start or resume antihypertensive medications
during hospitalization for patients with BP greater than
140/90 mmHg who are neurologically stable.
2. For patients with extracranial or intracranial large artery stenosis, a
slower reduction in BP (i.e., over 7 to 14 days after ischemic
stroke) is recommended in an effort to maintain cerebral blood
flow to ischemic brain regions.
aa. Contralateral carotid artery occlusion will result in compensatory increases in
flow velocities and thus could cause overestimation of the degree of stenosis.
bb. CHF, Excessive Calcification, Proximal CCA Disease, or Distal ICA Disease, can
result in falsely low flow velocities.
cc. Asymptomatic Hollenhorst plaques on fundoscopic exam are not considered symptomatic
carotid stenosis
dd. Carotid Endarterectomy is MODERATE cardiac risk surgery.
ee. Plaque Features:
i. Homogeneity suggests stable plaque
ii. Ulceration, Intraplaque hemorrhage, Lipid Rich Necrotic Core, Irregular
Surface and Heterogeneity suggest higher risk of rupture
iii. Echogenic plaque is calcium rich and is thought to be more stable.
iv. Echolucent plaque is more consistent with lipid rich or hemorrhagic plaque that is
more likely to be unstable
ff. Incidental asymptomatic cerebral aneurysms should be treated if >8mm
i. If smaller size, then asymptomatic ICA disease can be treated first.
gg. Patients with a Hollenhorst plaque should undergo evaluation; however, the
decision to treat a carotid stenosis can be made independent of the ocular finding.
i. They are age-indeterminate micro-atheroembolus from any proximal
cardiovascular structure. Thus, they are not specifically associated with
severe carotid disease, and have negligible stroke risk.
hh. Measurement of the degree of carotid stenosis can be performed by using one of the two
methods described in the North American Symptomatic Carotid Endarterectomy Trial
(NASCET *Normal Distal ICA) and the European Carotid Surgery Trial (ECST
*Estimate at location).
i. Both methods use the ratio of greatest stenosis to an approximate of normal, with
NASCET using the normal internal carotid artery distal to the bulb and ECST
using an estimate of the original width of the artery at the stenosis.
ii. CT angiography is that dense calcifications can obscure intraluminal contrast and lead to
overestimation of the degree of carotid stenosis.
i. MR angiography is not limited by calcification and should be used when
calcification limits CT angiography or duplex.
jj.
kk. Cerebral Hyperperfusion:
i. High mortality, 38%
ii. This syndrome is believed to be due to loss of vascular autoregulation at
the arteriolar level, resulting in cerebral edema and potentially progressing
to intracranial hemorrhage.
iii. Usually within 1-2 weeks, median 3 days
iv. The condition is not believed to be related to ongoing microembolization
or postoperative hypovolemia.
v. Elevated mean velocities in the middle cerebral artery may be observed
with transcranial Doppler
vi. Work-up:
1. Non-contrast CT
2. MRI (FLAIR) – Cerebral Edema, T2
vii. Treatment:
1. Aggressive BP Control
2. EEG, for subclinical seizure
3. Consider Stopping Antiplatelet/Antithrombotic
ll. Preoperative balloon occlusion testing combined with Xenon-enhanced SPECT
imaging has demonstrated safety with carotid sacrifice.
i. A study is considered low risk for postoperative ischemia if there are NO
neurological deficits and normal diffusion on SPECT.
ii. A balloon occlusion test is recommended to be performed for 30 minutes
of ipsilateral occlusion and is considered clinically positive if any
neurologic deficits present, with or without hypotensive challenge.
iii. The ratio of radioactivity in the ipsilateral versus the control hemisphere
with Xenon enhanced SPECT imaging has been added to the clinical test
to improves sensitivity.
1. A ratio of 0.9 and greater is considered a normal test and the
likelihood of stroke increases in a linear fashion as the ratio drops
below 0.9.
mm. For those performing selective shunts under general anesthesia, various
cerebral monitoring techniques have been used to direct shunt placement during
CEA, the most common of which is slowing and decreased amplitude of alpha
and beta waves on EEG.
i. Carotid stump pressures > 40 mm Hg do not require shunting.
ii. A > 15% decrease from baseline value in either hemisphere in cerebral
oximetry is the threshold for shunt placement.
iii. Severe slowing in the middle cerebral artery on transcranial Doppler
(TCD) examination correlates to postoperative stroke and may benefit
from shunt placement.
nn.
oo. For Acute thrombosis of the ICA during carotid stenting most appropriate first
step in this patient who is acutely neurologically decompensated is to attempt to
disaggregate the platelet plug and thrombus with administration of intra-arterial
abciximab and thrombolytic therapy directly into the ipsilateral carotid artery.
i. Endovascular salvage attempts may ensue, including suction
thrombectomy, repeat stenting, and balloon angioplasty.
ii. While conversion to CEA may ultimately be required, immediate
conversion may also be too time-consuming and physiologically stressful
for the patient
pp. Carotid Aneurysm, similar to popliteal artery aneurysms, the primary risk of
carotid aneurysms is associated with distal thromboembolism or atheroembolism
from intraluminal thrombus, instead of aneurysm rupture.
i. No studies have been performed to evaluate the efficacy of anticoagulation
for ipsilateral stroke risk reduction; therefore, currently invasive
reconstruction is recommended provided the patient is an appropriate
surgical candidate.
ii. Unlike carotid stenosis related to atherosclerotic disease, the degree of
intraluminal stenosis is not the primary determining factor to recommend
repair in the setting of a carotid artery aneurysm. There is no stenosis
threshold for repair, as any stenosis is likely the result of aneurysm sac
intramural thrombus, thus predisposing the patient to future ipsilateral
stroke.
qq. Carotid Dissection:
i. Stretch injury at C2-C3 level.
ii. Patient have triad of unilateral headache/face pain, stroke, Horner’s or are
asymptomatic
iii. Physiology of sympathetic nerve disruption along the carotid artery as a
cause of partial Horner’s syndrome (oculosympathetic syndrome),
including miosis and ptosis, but excluding anhidrosis.
iv. Generally not associated with hoarse voice since no mass-effect
v. Most are managed with anticoagulation
vi. CTA would show Intramural Hematoma with Crescent Sign
rr. FMD:
i. FMD most commonly affects carotid/renal arteries which are medium
sized vessels
ii. A nonatheromatous, noninflammatory, proliferative process
iii. Predominantly in women between 15 and 50 years of age
1. Accounts for less than 10% of cases of renovascular hypertension
iv. Its principal pathologic form involves primarily the media; it affects long,
unbranched segments of medium-sized conduit arteries such as the renal
artery and the internal carotid artery but has been observed in almost every
artery in the body
1. FMD occurs most frequently (>90%) in women between 20 and 60
years
v. FMD is the second most frequent cause of renal artery stenosis after
atherosclerosis and the most common cause of renal hypertension in
young individuals.
vi. Because FMD is a noninflammatory process, it is not associated with
anemia, thrombocytopenia, or the increased acutephase reactants that often
occur in patients with vasculitis.
vii. The histopathologic scheme classified FMD into three categories related
to the pathologic layer of the arterial wall affected— fibroplasia of the
intima, media, or adventitia (periarterial fibroplasia)
1.
viii. About 12.9% of patients with FMD (renal or carotid) had at least one
intracranial aneurysm.
1. The location of the extracranial FMD did not influence the
incidence of intracranial aneurysms, so all patients with FMD
require imaging for an intracranial aneurysm.
2. Although there are no formal guidelines mandating brain imaging
in patients with FMD, it would seem prudent based on the 12.9%
prevalence of intracranial aneurysms.
ix. Carotid FMD:
1. Can present as stroke in young woman
2. Locations are not same as typical atherosclerotic (branch points)
3. Registry show the extracranial carotid and vertebral arteries to be
nearly as often involved as the renal arteries, primarily in middle-
aged women.
a. Carotid FMD is associated with cerebral aneurysms and
FMD involving the renal arteries.
4. Among the four types of FMD, the internal carotid artery is most
often affected by medial fibroplasia, which results in an
arteriographic appearance resembling a string of beads seen in
80% to 95% of the lesions.
a. The arterial segments involved tend to be more distal than
in the case of arteriosclerosis; they are located in the middle
and distal segments of the extracranial internal carotid
artery
5. Vertebral artery disease is usually located at the level of the C2
vertebral body and does not extend intracranially
6. Intracranial aneurysms and occlusive disease. This is found in at
least 10% of patients with FMD in general and as many as 51% of
patients with internal carotid FMD in particular.
a. Solitary intracranial aneurysms are present in 80% of these
patients, but multiple aneurysms occur in the remaining
20%.
b. These aneurysms tend to be on the same side as the
extracranial carotid FMD.
c. They pose an independent threat of rupture and
hemorrhage, and their natural history has the potential to be
worsened by relief of a proximal stenosis
7. FMD is classified based on the layers of the wall that are affected
a. Medial FIBROplasia: Associated with the classic String of
Beads
i. #1
b. Perimedial Dysplasia:
i. Commonly affects renal arteries and is associated
with microaneurysms
ii. #2
c. Medial Hyperplasia:
i. Appears as a single, concentric stenosis or long
tapering stenosis
ii. #3
d. Intimal Fibroplasia:
i. Appears as a single, concentric stenosis or long
tapering stenosis
e. Adventitial Hyperplasia:
i. Very rare and is usually seen in localized stenosis
f. The presentation of FMD in the cerebrovascular
circulation is varied.
i. While both transient ischemic attacks and
cerebrovascular accidents have been reported, more
patients are asymptomatic and present with
incidental findings of FMD.
ii. Other benign presentations include pulsatile
tinnitus, a "whooshing" sound in the ear, and
headaches.
iii. Stroke is also a presentation
g. The treatment for asymptomatic carotid fibromuscular
dysplasia is antiplatelet therapy with aspirin.
i. In symptomatic patients, transluminal balloon
angioplasty can be considered.
1. Stents should be avoided, only used with
dissections or aneurysms
2. **Angioplasty is also preferred if there is
fibrodysplasia in peripheral vasculature
h. Patients who have FMD and present with a vertebral
dissection acutely started on anticoagulation therapy with
heparin and transition to NOAC, and treated if
symptomatic. Same as a regular vertebral dissection.
i. Those associated with FMD are typically proximal
and occur bilaterally.
i. Given the generally benign behavior of asymptomatic
disease, patients with asymptomatic carotid FMD should be
monitored and treated medically, with antiplatelet therapy
for primary stroke prevention.
i. There is no evidence to suggest a role for lipid-
lowering therapy in patients with isolated FMD,
although it should be considered as part of a
primary prevention strategy
j. Although asymptomatic lesions seem to have a generally
benign course, such may not be the case in a patient who
suffered a stroke on the contralateral side from the same
pathology
i. Patients with carotid FMD often have nonfocal
symptoms, some of which may be due to global
ischemia
k. Because of the relative safety and effectiveness of
mechanical intervention dilation of the artery is appropriate
for lesions causing focal ischemic events (hemispheric or
ocular) or episodes of cerebral hypoperfusion.
l. A lesion causing a focal cerebral ischemic event should be
considered for treatment because it remains a significant
threat.
m. Hypoperfusion is rare but can occur in the setting of
critical bilateral carotid FMD or even unilateral disease
when there is a significant defect in the circle of Willis.
n. Percutaneous transluminal angioplasty (PTA) has been
successful in the treatment of renal artery FMD, and carotid
angioplasty with stenting has a growing role in the
management of carotid disease; however, the results and
durability of balloon angioplasty for carotid FMD with or
without stent placement are not known.
o. It is not clear whether carotid balloon angioplasty should be
accompanied by stent placement in FMD. Stent placement
is not usually required after PTA in renal artery FMD
because the results are excellent without stents and the
patients are usually otherwise young and healthy with good
life expectancies.
i. In light of this paucity of cases, more time will be
required to determine the role of PTA with or
without stenting in the treatment of patients with
carotid FMD.
p. Patients with asymptomatic carotid stenosis secondary to
FMD should be started on a regimen of antiplatelet agents
q. Carotid FMD should be monitored at intervals of 6 months
with a noninvasive study
r. Chiropractic manipulation of the neck should be avoided,
as should sports that are likely to produce whiplash-type
neck injuries.
s. The main disadvantage of open surgical dilation is that it is
performed without imaging of the luminal surface. The
length of the arterial segment to undergo treatment must be
estimated. Kinks and coils must be managed by “feel”
without direct guidance
i. PTA has become the preferred approach for more
proximal internal carotid artery FMD.
t.
x. Renal FMD:
1. Unlike atherosclerotic renal artery stenosis, the origin of the renal
artery is often spared
2. Luminal narrowing leads to renal parenchymal damage and
ischemic nephropathy in patients with FMD.
a. However, this seems to be less important in patients with
FMD than in those with atherosclerotic RAS
b. In addition, renal perfusion correlates inversely with the
degree of stenosis in FMD but not in atherosclerotic RAS,
further emphasizing that FMD hypertension is more truly
renin-dependent than hypertension due to atherosclerosis
3.
1.
2. Obtain Vein Map, Catecholamines, Plasma Metanephrines (since
5% are pheochromocytoma)
3. Have malignant potential, low via the Lymphatics
4. Family members should be screened
jjj. Carotid Trauma:
i. Classified as Penetrating vs. Blunt, followed by Symptomatic vs.
Asymptomatic
ii.
iii. Treatment:
1. Exploration:
a. Penetrating with Zone-2
2. Carotid Stent:
a. Pseudoaneurysm
3. Anticoagulation: 3-6 months
a. Blunt Dissection or Thrombosis
kkk. Stump Syndrome:
i. Occurs as symptomatic carotid with occluded ICA
ii. Confirm with CTA/Angiogram since there may be a string-sign which was
not seen in a duplex
iii. A vault at the origin of the occluded ICA syndrome acts as a reservoir for
the fresh thrombus that can embolize of the ECA and into the brain via
retrograde flow through the supra/infra-orbital vessels
iv. Treatment:
1. E-CEA w/ Patch + Ligation of the ICA
2. Best results in patient with Amaurosis Fugax
lll. Radiation induced carotid disease occurs in area not typical of carotid disease
mmm. Carotid Restenosis:
i. Early: May Regress, rare progression to occlusion
1. Early restenosis is usually secondary to the development of intimal
hyperplasia, and lesions that develop after several years are most
frequently due to disease progression or the development of new
atherosclerotic disease.
2. Myointimal Hyperplasia
3. Less prone to embolization
ii. Late: Recurrent Extrinsic Atherosclerosis, Stroke Risk
iii. Overall incidence of restenosis is reported to occur between 5-14%. Very
few of these patients were symptomatic.
iv. Specifically, early (0-3 months) restenosis events are usually related to
incomplete endarterectomy and/or clamp site injury while restenosis
occurring outside the perioperative period out to 3 years postoperatively
most often are due to neointimal hyperplasia.
a. Neointimal hyperplastic lesions result from platelet
aggregation along the endarterectomized surface of the
vessel which leads to recruitment of inflammatory cells
which activate vascular smooth muscle cells.
b. The vascular smooth muscle cells migrate and proliferate
and contribute to interaction with fibroblasts leading to
collagen deposition. These lesions are smooth and regular
in appearance which is different than de novo
atherosclerotic disease which is often more focal, irregular
and characterized by heterogeneous plaque features.
c. For restenosis events after 3 years, frequently development
of metachronous atherosclerotic disease is frequently
implicated.
nnn. For stent ultrasound the presence of indwelling stents may falsely elevate
measured velocities, thereby causing a false-positive result at the time of
screening.
2. Vertebral Artery:
i. Branches of the external carotid artery also serve as important collateral
pathways to the vertebral artery.
1. The V3 segment of the vertebral artery receives anastomotic branches
from the occipital artery (most commonly) and the cervical ascending
artery.
2. Persistent fetal communications may also serve as important anastomic
bridges between the carotid and vertebral systems. These fetal
connections include the trigeminal, hypoglossal, proatlantal, and otic
arteries. When these bridges exist, the vertebral or basilar artery are
usually hypoplastic or incomplete.
ii.
b. The medial margin of the scalene fat pad is next mobilized, and
the fat pad is retracted laterally.
c. Mobilization of the fat pad exposes the underlying anterior
scalene muscle. The phrenic nerve is located on the ventral
surface of the anterior scalene muscle and is usually found
coursing near the muscle's medial border
d. The vertebral artery is located in the center of the angle formed
by the anterior scalene and longus colli muscles. The artery is
most easily identified and isolated by retracting the anterior
scalene laterally.
e.
f. The inferior thyroid branch of the thyrocervical trunk and
vertebral vein should be ligated
4. Anterior Cervical Approach:
a.
d. The carotid sheath and its contents are carefully freed by vertical
dissection along the lateral border of the internal jugular vein.
e. Avoid injury to the vagus nerve and sympathetic chain, which
course in the posterolateral aspect of the carotid sheath. Once
freed from surrounding tissue, the carotid sheath and its contents
are retracted medially
f. V2:
i.
v.